Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Influenza, Human × COVID-19 Vaccines × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

COVID-19 6 Neoplasms 2 Lung Neoplasms 2 Rheumatic Diseases 1 Papillomavirus Infections 1 Nervous System Diseases 1 Multiple Myeloma 1 Melanoma 1 Lymphoma 1 Leukemia 1 Influenza, Human 1 Hematologic Diseases 1 Chronic Disease 1 Breast Neoplasms 1

Interventions

Influenza Vaccines 14 trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine 2 Vaccines 2 Cyclophosphamide 2 ziprasidone 1 thymoglobulin 1 peginterferon alfa-2a 1 fludarabine 1 baloxavir 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Tobramycin 1 Spironolactone 1 Sevelamer 1 Rocuronium 1 Rituximab 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Oseltamivir 1 Nivolumab 1 Nifedipine 1 Nafcillin 1 Molindone 1 Methylprednisolone 1 Melphalan 1 Lurasidone Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06605625 2025-10-28

VRiC

Abramson Cancer Center at Penn Medicine

Active not recruiting

Influenza, Human

Data powered by HemOnc (CC BY 4.0) Colophon ⚡